Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge

NCT ID: NCT07034131

Last Updated: 2025-07-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-31

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a pilot randomised controlled trial (RCT) to evaluate the use of a Virtual Health Assistant (VHA) named Osteo-Buddy in improving the knowledge of osteoporosis in older women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will involve evaluating the preliminary effectiveness and feasibility outcomes of the use of Osteo-Buddy, a Virtual Health Assistant (VHA), in improving the knowledge of osteoporosis in women aged 50 and above.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoporosis Risk Osteoporosis, Postmenopausal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

use of Osteo-Buddy for 4 weeks

Group Type EXPERIMENTAL

Osteo-Buddy

Intervention Type OTHER

Osteo-Buddy is a Virtual Health Assistant (VHA) accessible on mobile phones that helps users with:

1. Evaluating their risk level of osteoporosis
2. Recommending screening and referrals
3. Lifestyle interventions through motivation, education and tailored guidance

As a 24/7 VHA, it offers real-time, personalised advice based on user inputs and health data.

Usual Care

Intervention Type OTHER

Access to digitalised educational materials on osteoporosis, titled 'Healthy Bones'

Control

usual care - access to digitalised educational materials titled 'Healthy Bones'

Group Type EXPERIMENTAL

Usual Care

Intervention Type OTHER

Access to digitalised educational materials on osteoporosis, titled 'Healthy Bones'

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Osteo-Buddy

Osteo-Buddy is a Virtual Health Assistant (VHA) accessible on mobile phones that helps users with:

1. Evaluating their risk level of osteoporosis
2. Recommending screening and referrals
3. Lifestyle interventions through motivation, education and tailored guidance

As a 24/7 VHA, it offers real-time, personalised advice based on user inputs and health data.

Intervention Type OTHER

Usual Care

Access to digitalised educational materials on osteoporosis, titled 'Healthy Bones'

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 50 and above
* Medium or high Osteoporosis Self-Assessment Tool for Asians (OSTA) score
* Not undertaken Bone Mineral Density (BMD) scan
* Never been treated with anti-osteoporosis medications such as bisphosphonates (e.g. alendronate, risendronate, ibandronate, zolendronate, pamidronate) or denosumab
* Able to read and speak English
* Currently use and own a smartphone where Osteo-Buddy can be used

Exclusion Criteria

* Known terminal illness
* Visual, hearing and/or cognitive impairment or mental illness that renders them unable to provide informed consent
Minimum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SingHealth Polyclinics

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eunice Lim Shi Min

Family Physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eunice Lim

Role: PRINCIPAL_INVESTIGATOR

SingHealth Polyclinics

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eunice Lim

Role: CONTACT

+65 6340 7436

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-0064

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Secondary Prevention of Osteoporosis
NCT00421343 COMPLETED PHASE3